141 related articles for article (PubMed ID: 2981982)
41. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
[TBL] [Abstract][Full Text] [Related]
42. A randomized trial comparing vindesine and cisplatinum to vindesine and methotrexate in advanced non small cell lung carcinoma.
Harvey VJ; Slevin ML; Cheek SP; Barnett MJ; Gregory W; Thompson JP; Wrigley PF
Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1615-9. PubMed ID: 2828071
[TBL] [Abstract][Full Text] [Related]
43. VP-16 and cisplatin in the treatment of non-small-cell lung cancer.
Klastersky J
Semin Oncol; 1985 Mar; 12(1 Suppl 2):17-20. PubMed ID: 4038820
[TBL] [Abstract][Full Text] [Related]
44. Progress in chemotherapy of non-small cell lung cancer.
Sculier JP; Klastersky J
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1329-33. PubMed ID: 6209142
[TBL] [Abstract][Full Text] [Related]
45. Comparison of cisplatin-paclitaxel combination versus cisplatin-etoposide in patients with small-cell lung cancer: a Phase III study.
Dimitroulis J; Rapti A; Stathopoulos GP; Rigatos S; Stathopoulos J; Koutantos J; Athanasiadis A; Tsikritsaki K; Karaindros D; Katis K; Antoniou D; Toumbis M; Giamboudakis P
Oncol Rep; 2008 Oct; 20(4):879-84. PubMed ID: 18813830
[TBL] [Abstract][Full Text] [Related]
46. A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
Sculier JP; Paesmans M; Lecomte J; Van Cutsem O; Lafitte JJ; Berghmans T; Koumakis G; Florin MC; Thiriaux J; Michel J; Giner V; Berchier MC; Mommen P; Ninane V; Klastersky J;
Br J Cancer; 2001 Nov; 85(10):1444-51. PubMed ID: 11720426
[TBL] [Abstract][Full Text] [Related]
47. Phase II study of vindesine, cisplatin, and hexamethylmelamine (VCH) in small cell carcinoma of the lung.
Daugaard G; Hansen HH; Rørth M
Cancer Treat Rep; 1984 Sep; 68(9):1179-81. PubMed ID: 6090016
[TBL] [Abstract][Full Text] [Related]
48. Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Segawa Y; Kiura K; Takigawa N; Kamei H; Harita S; Hiraki S; Watanabe Y; Sugimoto K; Shibayama T; Yonei T; Ueoka H; Takemoto M; Kanazawa S; Takata I; Nogami N; Hotta K; Hiraki A; Tabata M; Matsuo K; Tanimoto M
J Clin Oncol; 2010 Jul; 28(20):3299-306. PubMed ID: 20530281
[TBL] [Abstract][Full Text] [Related]
49. Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma.
Albain KS; Bitran JD; Golomb HM; Hoffman PC; DeMeester TR; Skosey C; Noble S; Blough RR
Cancer Treat Rep; 1984 Feb; 68(2):413-5. PubMed ID: 6538114
[TBL] [Abstract][Full Text] [Related]
50. Chemotherapy of advanced non-small-cell lung cancer: a randomized trial of three cis-platin-based chemotherapy regimens.
Hainsworth JD; Johnson DH; Hande KR; Greco FA
Am J Clin Oncol; 1989 Aug; 12(4):345-9. PubMed ID: 2547305
[TBL] [Abstract][Full Text] [Related]
51. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
[TBL] [Abstract][Full Text] [Related]
52. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.
Kelly K; Crowley J; Bunn PA; Presant CA; Grevstad PK; Moinpour CM; Ramsey SD; Wozniak AJ; Weiss GR; Moore DF; Israel VK; Livingston RB; Gandara DR
J Clin Oncol; 2001 Jul; 19(13):3210-8. PubMed ID: 11432888
[TBL] [Abstract][Full Text] [Related]
53. Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective, randomized study.
Valdivieso M; Burgess MA; Ewer MS; Mackay B; Wallace S; Benjamin RS; Ali MK; Bodey GP; Freireich EJ
J Clin Oncol; 1984 Mar; 2(3):207-14. PubMed ID: 6321689
[TBL] [Abstract][Full Text] [Related]
54. Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer. Results of a prospective randomized FONICAP trial. Italian Lung Cancer Task Force.
Rosso R; Salvati F; Ardizzoni A; Gallo Curcio C; Rubagotti A; Belli M; Castagneto B; Fusco V; Sassi M; Ferrara G
Cancer; 1990 Jul; 66(1):130-4. PubMed ID: 2162239
[TBL] [Abstract][Full Text] [Related]
55. Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.
Kris MG; Gralla RJ; Kelsen DP; Casper ES; Burke MT; Fiore JJ; Cibas IR; Heelan RT
Chest; 1985 Mar; 87(3):368-72. PubMed ID: 2982552
[TBL] [Abstract][Full Text] [Related]
56. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.
Wozniak AJ; Crowley JJ; Balcerzak SP; Weiss GR; Spiridonidis CH; Baker LH; Albain KS; Kelly K; Taylor SA; Gandara DR; Livingston RB
J Clin Oncol; 1998 Jul; 16(7):2459-65. PubMed ID: 9667264
[TBL] [Abstract][Full Text] [Related]
57. A prospective randomized trial of combination vindesine and cisplatin versus single-agent vindesine in advanced non-small cell lung cancer.
Popkin JD; Hong WK; Cersosimo RJ; Faling LJ; Snow MN; Fofonoff SA
Pharmacotherapy; 1985; 5(1):20-2. PubMed ID: 3885173
[TBL] [Abstract][Full Text] [Related]
58. Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancer.
Stuart-Harris R; Fox RM; Raghavan D; Coates AS; Hedley D; Levi JA; Woods RL; Tattersall MH
Thorax; 1985 May; 40(5):346-50. PubMed ID: 2410994
[TBL] [Abstract][Full Text] [Related]
59. [Chemotherapy of advanced non-small cell bronchogenic carcinoma with cisplatin and vindesine].
Drings P; Kleckow M; Manke HG; Stiefel E
Onkologie; 1984 Aug; 7(4):202-4. PubMed ID: 6384861
[TBL] [Abstract][Full Text] [Related]
60. PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study.
Voigt H; Kleeberg UR
Cancer; 1984 May; 53(10):2058-62. PubMed ID: 6231091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
